Ruidong Zhu - Concepedia

Author

Ruidong Zhu

Beijing YouAn Hospital ORCID

Also Known As

R Zhu, Ruchang Zhu, Rui-Dong Zhu, Ruidong Zhu, Ruocheng Zhu

Publications

262

Citations

H-Index

Concepts

All Affiliations

Beijing YouAn Hospital Capital Medical University Harbin Medical University Sichuan University First Affiliated Hospital of Chinese PLA General Hospital

About

Ruidong Zhu is an author at Beijing YouAn Hospital specializing in pathology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	12
2	Hepatology	1	1	12
3	Immunology	1	1	12
4	Pathology	1	1	12
5	Gene Therapies	1	1	12

Ruidong Zhu

Publications

242

Citations

H-Index

Page 1

	Year	Citations
Transcription Factor p53 Suppresses Tumor Growth by Prompting Pyroptosis in Non-Small-Cell Lung Cancer Tianze Zhang, Yongchao Li, Ruidong Zhu, Oxidative Medicine and Cellular Longevity	2019	89
CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection Feng Ji-liang, Ruidong Zhu, Chun Chang, PLoS ONE	2016	79
Prediction of Early Recurrence of Solitary Hepatocellular Carcinoma after Orthotopic Liver Transplantation Feng Ji-liang, Ruidong Zhu, Dezhao Feng, Scientific Reports	2019	19
Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation Feng Ji-liang, Jushan Wu, Ruidong Zhu, Scientific Reports	2017	16
Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection Feng Ji-liang, Junmei Chen, Ruidong Zhu, Oncotarget	2017	16
Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma Ruidong Zhu, Danhui Weng, Shichun Lu, Human Gene Therapy ImmunologyVascular InvasionPathologyAdvanced Hcc PatientsLiver Transplantation Outcomes	2018	12
Microarray Identifies a Key Carcinogenic Circular RNA 0008594 That Is Related to Non-Small-Cell Lung Cancer Development and Lymph Node Metastasis and Promotes NSCLC Progression by Regulating the miR-760-Mediated PI3K/AKT and MEK/ERK Pathways Qiushi Wang, Chunhua Yan, Pengfei Zhang, Frontiers in Oncology	2021	11

Page 1